DGX logo

Quest Diagnostics Incorporated (DGX) Cash From Financing

Annual CFF:

$1.08B+$924.00M(+577.50%)
December 31, 2024

Summary

  • As of today, DGX annual cash from financing is $1.08 billion, with the most recent change of +$924.00 million (+577.50%) on December 31, 2024.
  • During the last 3 years, DGX annual cash from financing has risen by +$3.62 billion (+142.68%).
  • DGX annual cash from financing is now at all-time high.

Performance

DGX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDGXcash flow metrics

Quarterly CFF:

-$247.00M+$46.00M(+15.70%)
September 30, 2025

Summary

  • As of today, DGX quarterly cash from financing is -$247.00 million, with the most recent change of +$46.00 million (+15.70%) on September 30, 2025.
  • Over the past year, DGX quarterly cash from financing has dropped by -$2.02 billion (-113.95%).
  • DGX quarterly cash from financing is now -113.95% below its all-time high of $1.77 billion, reached on September 30, 2024.

Performance

DGX Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDGXcash flow metrics

TTM CFF:

-$1.27B-$2.02B(-270.38%)
September 30, 2025

Summary

  • As of today, DGX TTM cash from financing is -$1.27 billion, with the most recent change of -$2.02 billion (-270.38%) on September 30, 2025.
  • Over the past year, DGX TTM cash from financing has dropped by -$2.65 billion (-191.84%).
  • DGX TTM cash from financing is now -191.84% below its all-time high of $1.38 billion, reached on September 30, 2024.

Performance

DGX TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDGXcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

DGX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+577.5%-114.0%-191.8%
3Y3 Years+142.7%+47.9%+18.3%
5Y5 Years+381.8%-375.0%-2117.5%

DGX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+142.7%-114.0%+56.0%-191.8%+26.6%
5Y5-Yearat high+142.7%-114.0%+84.2%-191.8%+57.7%
All-TimeAll-Timeat high+142.7%-114.0%+84.2%-191.8%+57.7%

DGX Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$247.00M(+15.7%)
-$1.27B(-270.4%)
Jun 2025
-
-$293.00M(+47.8%)
$746.00M(+10.4%)
Mar 2025
-
-$561.00M(-230.0%)
$676.00M(-37.6%)
Dec 2024
$1.08B(+577.5%)
-$170.00M(-109.6%)
$1.08B(-21.7%)
Sep 2024
-
$1.77B(+587.6%)
$1.38B(+395.1%)
Jun 2024
-
-$363.00M(-137.3%)
-$469.00M(-665.1%)
Mar 2024
-
-$153.00M(-217.7%)
$83.00M(-48.1%)
Dec 2023
$160.00M(+109.2%)
$130.00M(+256.6%)
$160.00M(+131.1%)
Sep 2023
-
-$83.00M(-143.9%)
-$515.00M(+43.2%)
Jun 2023
-
$189.00M(+348.7%)
-$906.00M(+32.2%)
Mar 2023
-
-$76.00M(+86.1%)
-$1.34B(+22.8%)
Dec 2022
-$1.73B(+31.8%)
-$545.00M(-15.0%)
-$1.73B(-11.3%)
Sep 2022
-
-$474.00M(-95.9%)
-$1.56B(-38.9%)
Jun 2022
-
-$242.00M(+48.6%)
-$1.12B(+54.2%)
Mar 2022
-
-$471.00M(-27.6%)
-$2.44B(+3.7%)
Dec 2021
-$2.54B(-100.5%)
-$369.00M(-871.1%)
-$2.54B(+15.1%)
Sep 2021
-
-$38.00M(+97.6%)
-$2.99B(+0.5%)
Jun 2021
-
-$1.57B(-176.9%)
-$3.00B(-219.0%)
Mar 2021
-
-$566.00M(+31.0%)
-$942.00M(+25.7%)
Dec 2020
-$1.27B(-663.1%)
-$820.00M(-1476.9%)
-$1.27B(-2111.1%)
Sep 2020
-
-$52.00M(-110.5%)
$63.00M(-26.7%)
Jun 2020
-
$496.00M(+155.7%)
$86.00M(+110.4%)
Mar 2020
-
-$891.00M(-274.7%)
-$830.00M(-468.9%)
Dec 2019
$225.00M(+156.1%)
$510.00M(+1858.6%)
$225.00M(+161.5%)
Sep 2019
-
-$29.00M(+93.1%)
-$366.00M(+25.5%)
Jun 2019
-
-$420.00M(-356.1%)
-$491.00M(-87.4%)
Mar 2019
-
$164.00M(+302.5%)
-$262.00M(+37.2%)
Dec 2018
-$401.00M(+32.3%)
-$81.00M(+47.4%)
-$417.00M(+18.2%)
Sep 2018
-
-$154.00M(+19.4%)
-$510.00M(-17.2%)
Jun 2018
-
-$191.00M(-2222.2%)
-$435.00M(-3.3%)
Mar 2018
-
$9.00M(+105.2%)
-$421.00M(+29.4%)
Dec 2017
-$592.00M(+19.8%)
-$174.00M(-120.3%)
-$596.00M(+10.5%)
Sep 2017
-
-$79.00M(+55.4%)
-$666.00M(+3.9%)
Jun 2017
-
-$177.00M(-6.6%)
-$693.00M(+22.0%)
Mar 2017
-
-$166.00M(+32.0%)
-$889.00M(-28.7%)
Dec 2016
-$738.00M(-42.5%)
-$244.00M(-130.2%)
-$691.00M(-16.1%)
Sep 2016
-
-$106.00M(+71.6%)
-$595.00M(+10.5%)
Jun 2016
-
-$373.00M(-1265.6%)
-$665.00M(+49.7%)
Mar 2016
-
$32.00M(+121.6%)
-$1.32B(-132.1%)
Dec 2015
-$518.00M(-702.3%)
-$148.00M(+15.9%)
-$570.00M(+6.9%)
Sep 2015
-
-$176.00M(+82.9%)
-$612.00M(-4.1%)
Jun 2015
-
-$1.03B(-231.3%)
-$588.00M(-259.8%)
Mar 2015
-
$785.00M(+513.2%)
$368.00M(+300.0%)
Dec 2014
$86.00M(+107.8%)
-$190.00M(-25.0%)
$92.00M(-55.3%)
Sep 2014
-
-$152.00M(-102.7%)
$205.83M(+175.8%)
Jun 2014
-
-$75.00M(-114.7%)
-$271.56M(+49.5%)
Mar 2014
-
$509.00M(+768.2%)
-$537.30M(+51.4%)
Dec 2013
-$1.11B(-34.5%)
-$76.17M(+87.9%)
-$1.11B(+11.3%)
Sep 2013
-
-$629.39M(-84.7%)
-$1.25B(-31.3%)
Jun 2013
-
-$340.74M(-470.8%)
-$949.80M(-21.1%)
Mar 2013
-
-$59.70M(+72.5%)
-$784.32M(+4.6%)
Dec 2012
-$822.00M(-1384.4%)
-$217.21M(+34.6%)
-$822.10M(+3.0%)
Sep 2012
-
-$332.14M(-89.5%)
-$847.19M(-15.7%)
Jun 2012
-
-$175.27M(-79.8%)
-$731.99M(-59.5%)
Mar 2012
-
-$97.47M(+59.8%)
-$459.04M(-822.4%)
Dec 2011
$64.00M
-$242.31M(-11.7%)
$63.55M(-48.3%)
Sep 2011
-
-$216.95M(-322.1%)
$122.98M(+686.1%)
Jun 2011
-
$97.69M(-77.0%)
-$20.98M(+92.9%)
DateAnnualQuarterlyTTM
Mar 2011
-
$425.11M(+332.5%)
-$293.74M(+70.2%)
Dec 2010
-$986.49M(-89.3%)
-$182.87M(+49.3%)
-$986.49M(-20.2%)
Sep 2010
-
-$360.91M(-106.2%)
-$821.00M(-24.4%)
Jun 2010
-
-$175.07M(+34.6%)
-$659.78M(-29.9%)
Mar 2010
-
-$267.64M(-1439.5%)
-$507.72M(+2.6%)
Dec 2009
-$521.20M(+33.0%)
-$17.39M(+91.3%)
-$521.20M(+36.2%)
Sep 2009
-
-$199.69M(-767.9%)
-$817.07M(-8.1%)
Jun 2009
-
-$23.01M(+91.8%)
-$755.51M(+17.9%)
Mar 2009
-
-$281.12M(+10.3%)
-$920.68M(-18.4%)
Dec 2008
-$777.81M(-191.5%)
-$313.25M(-126.8%)
-$777.81M(-9.9%)
Sep 2008
-
-$138.12M(+26.6%)
-$707.86M(+4.8%)
Jun 2008
-
-$188.18M(-36.1%)
-$743.78M(-246.2%)
Mar 2008
-
-$138.26M(+43.2%)
$508.81M(-40.2%)
Dec 2007
$850.22M(+277.1%)
-$243.30M(-39.8%)
$850.22M(-5.0%)
Sep 2007
-
-$174.05M(-116.4%)
$895.10M(-15.9%)
Jun 2007
-
$1.06B(+424.0%)
$1.06B(+928.4%)
Mar 2007
-
$203.15M(+202.4%)
-$128.50M(+73.2%)
Dec 2006
-$479.98M(-294.3%)
-$198.42M(-4129.0%)
-$479.98M(-448.1%)
Sep 2006
-
-$4.69M(+96.3%)
$137.88M(+220.5%)
Jun 2006
-
-$128.53M(+13.4%)
$43.02M(-70.7%)
Mar 2006
-
-$148.34M(-135.4%)
$146.68M(-40.6%)
Dec 2005
$247.04M(+135.0%)
$419.44M(+521.3%)
$247.04M(+147.5%)
Sep 2005
-
-$99.56M(-300.3%)
-$519.78M(+2.5%)
Jun 2005
-
-$24.87M(+48.2%)
-$533.28M(+26.4%)
Mar 2005
-
-$47.98M(+86.2%)
-$724.60M(-2.5%)
Dec 2004
-$706.74M(-276.8%)
-$347.38M(-207.3%)
-$706.74M(-40.7%)
Sep 2004
-
-$113.06M(+47.7%)
-$502.35M(+3.1%)
Jun 2004
-
-$216.18M(-617.8%)
-$518.41M(-31.3%)
Mar 2004
-
-$30.12M(+78.9%)
-$394.70M(-110.4%)
Dec 2003
-$187.57M(-29.6%)
-$142.99M(-10.7%)
-$187.57M(+30.7%)
Sep 2003
-
-$129.12M(-39.6%)
-$270.67M(-24.2%)
Jun 2003
-
-$92.47M(-152.2%)
-$217.85M(-945.8%)
Mar 2003
-
$177.01M(+178.3%)
$25.76M(+117.8%)
Dec 2002
-$144.71M(+33.7%)
-$226.09M(-196.3%)
-$144.71M(-160.0%)
Sep 2002
-
-$76.30M(-150.5%)
-$55.66M(-72.3%)
Jun 2002
-
$151.13M(+2209.5%)
-$32.29M(+84.7%)
Mar 2002
-
$6.54M(+104.8%)
-$210.58M(+3.6%)
Dec 2001
-$218.33M(-23.2%)
-$137.04M(-158.9%)
-$218.33M(+7.9%)
Sep 2001
-
-$52.93M(-95.0%)
-$237.02M(-27.6%)
Jun 2001
-
-$27.15M(-2143.8%)
-$185.74M(-11.2%)
Mar 2001
-
-$1.21M(+99.2%)
-$166.98M(+5.8%)
Dec 2000
-$177.25M(-126.0%)
-$155.72M(-9297.8%)
-$177.25M(-147.3%)
Sep 2000
-
-$1.66M(+80.3%)
-$71.67M(-109.8%)
Jun 2000
-
-$8.39M(+26.9%)
$734.05M(+1.2%)
Mar 2000
-
-$11.48M(+77.1%)
$725.64M(+6.3%)
Dec 1999
$682.80M(+1230.5%)
-$50.15M(-106.2%)
$682.83M(-6.3%)
Sep 1999
-
$804.06M(+4885.8%)
$729.01M(+823.1%)
Jun 1999
-
-$16.80M(+69.0%)
-$100.82M(+5.6%)
Mar 1999
-
-$54.28M(-1268.7%)
-$106.79M(-76.8%)
Dec 1998
-$60.40M(-180.9%)
-$3.97M(+84.6%)
-$60.41M(-4.6%)
Sep 1998
-
-$25.77M(-13.2%)
-$57.75M(-80.0%)
Jun 1998
-
-$22.77M(-187.9%)
-$32.08M(-237.4%)
Mar 1998
-
-$7.91M(-508.5%)
-$9.51M(+55.8%)
Dec 1997
-$21.50M(-113.6%)
-$1.30M(-1200.0%)
-$21.50M(-6.4%)
Sep 1997
-
-$100.00K(+50.0%)
-$20.20M(-0.5%)
Jun 1997
-
-$200.00K(+99.0%)
-$20.10M(-1.0%)
Mar 1997
-
-$19.90M
-$19.90M
Dec 1996
$157.67M
-
-

FAQ

  • What is Quest Diagnostics Incorporated annual cash from financing?
  • What is the all-time high annual cash from financing for Quest Diagnostics Incorporated?
  • What is Quest Diagnostics Incorporated annual cash from financing year-on-year change?
  • What is Quest Diagnostics Incorporated quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Quest Diagnostics Incorporated?
  • What is Quest Diagnostics Incorporated quarterly cash from financing year-on-year change?
  • What is Quest Diagnostics Incorporated TTM cash from financing?
  • What is the all-time high TTM cash from financing for Quest Diagnostics Incorporated?
  • What is Quest Diagnostics Incorporated TTM cash from financing year-on-year change?

What is Quest Diagnostics Incorporated annual cash from financing?

The current annual cash from financing of DGX is $1.08B

What is the all-time high annual cash from financing for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated all-time high annual cash from financing is $1.08B

What is Quest Diagnostics Incorporated annual cash from financing year-on-year change?

Over the past year, DGX annual cash from financing has changed by +$924.00M (+577.50%)

What is Quest Diagnostics Incorporated quarterly cash from financing?

The current quarterly cash from financing of DGX is -$247.00M

What is the all-time high quarterly cash from financing for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated all-time high quarterly cash from financing is $1.77B

What is Quest Diagnostics Incorporated quarterly cash from financing year-on-year change?

Over the past year, DGX quarterly cash from financing has changed by -$2.02B (-113.95%)

What is Quest Diagnostics Incorporated TTM cash from financing?

The current TTM cash from financing of DGX is -$1.27B

What is the all-time high TTM cash from financing for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated all-time high TTM cash from financing is $1.38B

What is Quest Diagnostics Incorporated TTM cash from financing year-on-year change?

Over the past year, DGX TTM cash from financing has changed by -$2.65B (-191.84%)
On this page